Global Tinea Pedis Treatment Market By Treatment Type (OTC Medication Prescription Medication, Alternative Therapies and Others), Route of Administration (Oral, Topical and Others), End Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2027
Global tinea pedis treatment market is rising gradually with a substantial CAGR in the forecast period of 2020-2027. The report contains data of the base year 2019 and historic year 2018. Prevelance of tinea pedis amongst the population contributes towards this market growth.
Get Sample Report + All Related Graphs & Charts @
Key Market Players:
Few of the major competitors currently working in the global tinea pedis treatment market are Blueberry Therapeutics Ltd, Glenmark Pharmaceuticals Limited, Exeltis USA, Inc., Bausch Health, Pfizer Inc., Dr. Reddy’s Laboratories Ltd., Taro Pharmaceutical Industries Ltd., Merck & Co., Inc., AbbVie Inc., Alkermes, Takeda Pharmaceutical Company Limited,. Perrigo Company plc, Mylan N.V., Hikma Pharmaceuticals PLC, Mallinckrodt among others.
Market Definition: Global Tinea Pedis Treatment Market
Tinea pedis or Athlete’s foot is a contagious fungal infection usually begins between the toes. It can also spread into toe nails and hands. This infection occurs by sweating in feet while usage of tight fitting shoes. It can be characterized by skin fissures or red and itchy skin scales.
It was estimated that around70% of the population is reported to be infected with Tinea pedis at least once.
Global tinea pedis treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of tinea pedis treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Table Of Content: Tinea Pedis Treatment Market
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Tinea Pedis Treatment Market
Part 04: Global Tinea Pedis Treatment Market Sizing
Part 05: Global Tinea Pedis Treatment Market Segmentation By Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers And Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis
Get A Detailed Free TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-tinea-pedis-treatment-market
- Increasing research and development of highly specific antifungal drugs will drive the market growth
- Presence of a large immunocompromised patient pool will boost up the market growth
- High prevalence of tinea pedis is expected to increase the market size
- Increasing geriatric population with low immunity will fuel up the growth of market
- Lack of awareness of tinea pedis and its treatment options hampers the market growth
- Stringent approval process for new drugs and therapies obstructs the growth of the market
- Side effects associated with antifungal drugs and development of resistance restrains the market growth
Grab Your Report at an Impressive Discount! Please click [email protected]https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-tinea-pedis-treatment-market
Segmentation: Global Tinea Pedis Treatment Market
- OTC Medication
- Prescription Medication
- Alternative Therapies
By Route of Administration
By End Users
- Specialty Clinics
By Distribution Channels
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Key Developments in the Market:
- In December 2018, Glenmark Pharmaceuticals announced a foray into the branded dermatology market in the United States, the purpose for the expansion of the company is to develop and commercialize branded dermatological products in the USA. In support of this, company acquired seven branded dermatological products from Exeltis USA, Inc. including Ecoza (econazole), a topical antifungal drug used for treatment of tinea pedis, among all seven products
- In November 2018, Blueberry Therapeutics Ltd announced positive results of phase I/II clinical trial studies of its drug candidate BB2603 used for the treatment of patients with both onychomycosis (fungal nail infection) and concomitant tinea pedis (athletes foot). This clinical study was conducted to evaluate safety and efficacy of the drug. The results reported excellent safety profile with minimum local side effects and no systemic exposure. This clinical data will support the drug and facilitates the investigational new drug application (IND).
Reasons to Purchase this Report
- Current and future of global tinea pedis treatment market outlook in the developed and emerging markets
- The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
- Regions/Countries that are expected to witness the fastest growth rates during the forecast period
- The latest developments, market shares, and strategies that are employed by the major market players
The report provides insights on the following points:
- Learn about the market strategies that are being adopted by your competitors and leading organizations
- Market Penetration: Comprehensive information on the product portfolios of the top players in the trocars market
- To gain insightful analyses of the market and have a comprehensive understanding of the “Tinea Pedis Treatment Market ” and its commercial landscape
- To understand the future outlook and prospects for Tinea Pedis Treatment Market analysis and forecast 2019-2026.
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the market
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: [email protected]